Machine Learning

A new drug targeting the root cause of deadly device infections enters a pivotal trial, offering hope to millions and challenging a $20 billion problem.

Extreme Connect 2026 showcases an AI-first strategy to challenge industry giants, promising a new era of automated, intelligent enterprise networks.

As Zepp Health unveils its 2025 performance, all eyes are on its fight for profitability and market share against giants like Garmin and Apple.

New report shows LinkedIn is the only platform with positive B2B ROAS, as the customer journey becomes a complex, seven-month marathon of self-education.

As D-Wave prepares for a major physics summit, its unique dual-platform strategy and new gate-model breakthroughs could challenge industry giants.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

Promising clinical trial results for Insulet's fully closed-loop system aim to revolutionize daily management for millions with Type 2 diabetes.

Paperpal's new HIPAA-ready AI platform for life sciences offers secure data handling, aiming to accelerate research while ensuring regulatory compliance.

Following a stock drop, SES AI launches a global tour to showcase its AI-driven battery tech, pivoting focus from EVs to energy storage and drones.

A new venture platform backed by industry veterans launches a hands-on incubator to solve key challenges for startups in the booming pet technology ecosystem.

Facing a labor crisis, Wilson James is deploying an AI platform to optimize operations and empower its workforce with flexible, transparent scheduling.

Alzheon's pill ALZ-801 shows promise in early AD patients with high genetic risk, offering a potential path that avoids the brain swelling seen in IV drugs.

After selling assets and raising cash, Q32 Bio focuses all its resources on bempikibart, a novel drug for hair loss, with pivotal data due in 2026.

Eve Air Mobility, Alt Air, and Skyports team up to launch eVTOL services in NSW and Queensland, with an eye on the Brisbane 2032 Olympic Games.

A new industry report claims mining for green minerals is low-emission, but reveals the real climate fight is decarbonizing steel and aluminum production.

Glasswall's new AI solution, Foresight, promises to predict unknown malware by analyzing file DNA, shifting security from reactive to proactive defense.

A global consortium pioneers new drugs designed specifically for children, moving away from harsh adult treatments for aggressive pediatric cancers.

ViruSure's new GMP-validated test using Oxford Nanopore sequencing promises to slash drug safety testing times, boosting supply chain resilience.

As India's retail investor base explodes, a decade-old zero-brokerage model gets a high-tech upgrade, challenging rivals to offer more than just low costs.

With new Pro Series models and an AI-driven control system, XCMG is challenging construction giants on their home turf. Is their tailored strategy enough?